Understanding how certain brain tumors grow and how to target them
MECHANISMS OF POL II ELONGATION IN DIFFUSE MIDLINE GLIOMA
This study is looking at how certain changes in proteins can help aggressive brain tumors called diffuse midline gliomas grow, and it aims to find new ways to treat these tumors to help patients live longer and healthier lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11016994 on NIH RePORTER |
What this research studies
This research focuses on diffuse midline gliomas (DMGs), aggressive brain tumors that affect both children and adults. It investigates the role of specific mutations in histone proteins that disrupt normal gene transcription, contributing to tumor growth. By using advanced techniques like CRISPR, the study aims to identify key molecular pathways involved in these tumors, which could lead to new treatment strategies. The ultimate goal is to find effective therapies that can improve survival rates for patients with DMGs.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with diffuse midline gliomas, both pediatric and adult populations.
Not a fit: Patients with other types of brain tumors or those without the specific histone mutations associated with DMGs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of targeted therapies that significantly improve survival rates for patients with diffuse midline gliomas.
How similar studies have performed: While there have been initial studies targeting transcriptional dysregulation in brain tumors, this research aims to explore novel pathways that have not yet been fully tested in clinical settings.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Anastas, Jamie N. — Baylor College of Medicine
- Study coordinator: Anastas, Jamie N.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.